
About T-3 Molecular Genetics (T-3 Mgen) Private Limited
Data last updated:
T-3 Molecular Genetics (T-3 Mgen) Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 20 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2021PTC149735.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.05 Lakh. It is led by directors including Narendra Dnyanoba Dhele and Shankarrao Baburao Patil.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Bangalore Bioinnovation Centr (Bbc) Electronic City Phase – 1 Kar – 560100, Karnataka, India – 560100.
As per the financials filed for FY 2023, the company reported a revenue of ₹30,060, a decline of 60% compared to the previous year. For the same year it recorded a net loss of ₹1.62 Lakh and EBITDA of -₹1.16 Lakh (EBITDA margin -387.3%).
The company is associated with 1 brand: T3 MGen.
T-3 Molecular Genetics (T-3 Mgen) Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0137645). For more details, the company can be reached via its website t3mgen.com.
Company details
Recognitions & Rankings of T-3 Molecular Genetics (T-3 Mgen)
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-03-0137645
Contact details
T-3 Molecular Genetics (T-3 Mgen) Private Limited's registered office is in Bangalore, Karnataka. Its website is t3mgen.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressBangalore Bioinnovation Centr (Bbc) Electronic City Phase – 1 Kar – 560100, Karnataka, India – 560100
- IndustryLife Sciences, Biotechnology
To see the full contact details of T-3 Molecular Genetics (T-3 Mgen) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
T-3 Molecular Genetics (T-3 Mgen) operates one associated brand: T3 MGen. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops proprietary technologies for immune therapeutics against diseases using AI and multidisciplinary research. | t3mgen.com |
Business activity
The main business activity of T-3 Molecular Genetics (T-3 Mgen) is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of T-3 Molecular Genetics (T-3 Mgen) Private Limited, buy the company report.
Financials of T-3 Molecular Genetics (T-3 Mgen) Private Limited
FY 2023 filings availableT-3 Molecular Genetics (T-3 Mgen) Private Limited reported revenue of ₹30,060 (down 60% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 60% in the latest year. EBITDA rose 45% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹1.16 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹1.62 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -387.3% | |
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of T-3 Molecular Genetics (T-3 Mgen) Private Limited, buy the company report.
Board of directors of T-3 Molecular Genetics (T-3 Mgen) Private Limited
T-3 Molecular Genetics (T-3 Mgen) has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narendra Dnyanoba Dhele Also directs: T-3 Agrotech Private Limited | Director | 20 Jul 2021 | 5 Years 3 Months | Current |
| Shankarrao Baburao Patil | Director | 20 Jul 2021 | 5 Years 3 Months | Current |
| Nameirakpam Bunindro Singh Also directs: Leishen LLP | Director | 20 Jul 2021 | 5 Years 3 Months | Current |
Auditor
T-3 Molecular Genetics (T-3 Mgen) Private Limited is audited by MORDE & RETWADE for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MORDE & RETWADE | FY 2022 | 188365 |
Shareholding
The shareholding of T-3 Molecular Genetics (T-3 Mgen) Private Limited is on record for FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of T-3 Molecular Genetics (T-3 Mgen) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving T-3 Molecular Genetics (T-3 Mgen) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for T-3 Molecular Genetics (T-3 Mgen) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for T-3 Molecular Genetics (T-3 Mgen) Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
T-3 Molecular Genetics (T-3 Mgen) Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Nameirakpam Bunindro Singh was appointed as Director on 20 Jul 2021.
Frequently asked questions
T-3 Molecular Genetics (T-3 Mgen) is an active private limited company based in Bangalore, Karnataka, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 20 July 2021 (5+ years old) and is registered under CIN U73100KA2021PTC149735.
T-3 Molecular Genetics (T-3 Mgen) has 3 current directors:
- Narendra Dnyanoba Dhele - Director
- Shankarrao Baburao Patil - Director
- Nameirakpam Bunindro Singh - Director
The latest financial statements of T-3 Molecular Genetics (T-3 Mgen) on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of T-3 Molecular Genetics (T-3 Mgen) is U73100KA2021PTC149735. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
T-3 Molecular Genetics (T-3 Mgen) was incorporated on 20 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Bangalore.
Nameirakpam Bunindro Singh was appointed as Director on 20 Jul 2021. Narendra Dnyanoba Dhele was appointed as Director on 20 Jul 2021. Shankarrao Baburao Patil was appointed as Director on 20 Jul 2021.
Yes, T-3 Molecular Genetics (T-3 Mgen) is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, T-3 Molecular Genetics (T-3 Mgen) is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0137645).
T-3 Molecular Genetics (T-3 Mgen) can be reached through the website t3mgen.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of T-3 Molecular Genetics (T-3 Mgen) is at Bangalore Bioinnovation Centr Bbc Electronic City Phase – 1 Kar – 560100, Karnataka, India – 560100.

